India's Reliance stops importing Russian crude for refinery operations-February 2024-www.financetom.com

India's Reliance stops importing Russian crude for refinery operations

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

India's Reliance stops importing Russian crude for refinery operations

Nov 20, 2025 11:40 AM

NEW DELHI, Nov 20 (Reuters) - India's Reliance

has stopped importing Russian crude oil into its refining

complex at Jamnagar in western Gujarat state, effective November

20, its spokesperson said on Thursday.

Reliance had earlier said that the refiner will abide by

Western sanctions against Moscow.

(Reporting by Sethuraman NR)

Previous page： Uranium Royalty Buys Royalty on Cameco's Millennium, Cree Extension Projects in Saskatchewan for $6 Million Next page： Acadia Realty Trust's Q3 Funds From Operations, Revenue Rise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Uranium Royalty Buys Royalty on Cameco's Millennium, Cree Extension Projects in Saskatchewan for $6 Million

Oct 28, 2024

07:17 AM EDT, 10/28/2024 (MT Newswires) -- Uranium Royalty ( UROY ) said Monday that it acquired an existing royalty on the Millennium and Cree Extension uranium projects in Saskatchewan for $6 million. The company said the royalty is a net profit interest of 10% on an approximate 21% stake in the projects, which are operated by Cameco ( CCJ...

Acadia Realty Trust's Q3 Funds From Operations, Revenue Rise

Oct 28, 2024

07:51 AM EDT, 10/28/2024 (MT Newswires) -- Acadia Realty Trust ( AKR ) reported Q3 funds from operations Monday of $0.28 per share, up from $0.26 a year earlier. Analysts polled by Capital IQ expected $0.31. Revenue for the quarter ended Sept. 30 was $87.7 million, compared with $81.4 million a year earlier. Three analysts surveyed by Capital IQ expected...

Monte Rosa Therapeutics Enters Global License Deal With Novartis; Shares Jump Pre-Bell

Oct 28, 2024

07:47 AM EDT, 10/28/2024 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said Monday that it has entered into a global development and commercialization license agreement with Novartis ( NVS ) for VAV1-directed molecular glue degraders, including MRT-6160. The agreement gives Novartis ( NVS ) exclusive global rights to develop, manufacture, and commercialize MRT-6160 and other VAV1 MGDs, Monte...

Top Premarket Gainers

Oct 28, 2024

07:48 AM EDT, 10/28/2024 (MT Newswires) -- Evoke Pharma ( EVOK ) shares surged more than 130% pre-bell Monday after the company reported results from a real-world study showing significant statistical improvement for its diabetic gastroparesis nasal therapy over oral metoclopramide. Monte Rosa Therapeutics ( GLUE ) shares advanced 42% after the company said it secured a global license deal...